For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Argentinean Tango | A biweekly 3-month tango program Argentinean Tango classes: Tango participants will attend an 1-hour Argentinean Tango classes twice a week during 12 weeks, with experienced professional tango instructors. | None | None | 0 | 18 | 4 | 18 | View |
| A 'Wait-list' Control Group | Patient information about exercise in PD. After 12 weeks, these patients will then start the same 12-weeks tango program. Simple pamphlet about the exercise in PD: Controls will follow their usual schedule of pharmacological treatment; will be provided by simple pamphlet about the exercise in PD, and will otherwise to go about their lives as usual. | None | None | 0 | 15 | 2 | 15 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| respiratory infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Falls | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| mild fatigue and muscle cramps | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |